NCT01049022 Safety, Tolerability and Pharmacokinetics of Single Dose Intravenous Moxifloxacin in Pediatric Patients Status COMPLETED Phase PHASE1
NCT01043523 Liver MRI With Primovist/Eovist in Pediatric Subjects Who Are Suspected or Have Focal Liver Lesions. Status COMPLETED Phase N/A
NCT01038869 Efficacy and Safety Study of Finacea to Treat Acne Vulgaris and Post-Inflammatory Hyperpigmentation (PIH) Status COMPLETED Phase PHASE4
NCT01035164 Evaluation of ZK 6032924 in Probable Alzheimer's Disease Patients Versus Healthy Volunteers and the Radiation Dosimetry of ZK 6032924 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01032850 Sorafenib With Capecitabine for Patients With Measurable Hepatocellular Carcinoma Status TERMINATED Phase PHASE2
NCT01031459 Telephone Interview of Patients That Participated in the the Pivotal Betaferon MS Trial. Status COMPLETED Phase N/A
NCT01031355 Bioequivalence Study: 3 mg Estradiol Valerate (EV) With and Without Levomefolate Calcium Status COMPLETED Phase PHASE1
NCT01031199 Evaluation of the Positron Emission Tomography (PET) Tracer ZK 6032924 in Patients With Multiple Sclerosis Compared to Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01029340 Trial to Evaluate the Efficacy and Safety of a New Full Length Recombinant Human FVIII for Hemophilia A Status COMPLETED Phase PHASE3
NCT01028755 To Determine Maximum Tolerated Dose of BAY79-4620 in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01028079 Placebo and Active Controlled, Double Dummy Study to Prove Efficacy of Aspirin in Treatment of Acute Low Back Pain Status COMPLETED Phase PHASE3
NCT01025635 Safety and Efficacy of Azelaic Acid Foam, 15% in Papulopustular Rosacea Status COMPLETED Phase PHASE2
NCT01021436 Safety, Tolerability and Pharmacokinetics of Aerosolized Amikacin in Intubated and Mechanically-ventilated Patients With Nosocomial Pneumonia Status COMPLETED Phase PHASE2
NCT01015625 Primary Operation in SYnchronous meTastasized InVasivE Breast Cancer Status COMPLETED Phase NA
NCT01014247 Influence of Moxifloxacin on QTc Interval in Healthy Subjects for Positive Control Validation Status COMPLETED Phase PHASE1